BSECompany Update5h ago · 22 Jul 2026, 11:46 am

Newspaper Publication on Unaudited Consolidated and Standalone Financial Results for the quarter ended June 30, 2026

Anthem Biosciences Ltd · 544449

✦ AI SummaryResults

Anthem Biosciences Ltd has published its unaudited consolidated and standalone financial results for the quarter ended June 30, 2026, in accordance with Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Analysis Scores

Earnings Impact5/10

Growth Catalyst2/10

Governance Concern1/10

Regulatory Risk1/10

Balance Sheet Risk2/10

Liquidity Impact8/10

Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

Full Announcement

Anthem Biosciences Ltd - 544449 - Announcement under Regulation 30 (LODR)-Newspaper Publication

Attachments (1)

📄

60bdf180-b25e-429b-846f-08223ac71ca5.pdf

pdf

Download →

View document text

Date: July 22, 2026 BSE Limited, National Stock Exchange of India Limited 20th Floor, P.J. Towers, Exchange Plaza, C-1, Block G, Dalal Street, Bandra Kurla Complex, Bandra (E), Mumbai - 400001. Mumbai – 400 051 BSE Scrip Code: 544449 NSE Scrip Symbol: ANTHEM Subject: Newspaper Advertisement of Unaudited Consolidated and Standalone Financial Results for the quarter ended June 30, 2026 Dear Sir/Ma’am Pursuant to Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith the copies of the newspaper advertisement pertaining to the Unaudited Consolidated and Standalone Financial Results of the Company for the quarter ended June 30, 2026, published on July 22, 2026 in following newspapers: 1. Financial Express (English Edition) 2. Vishwavani (Kannada Edition) We request you to kindly take the same on record. Thanking you, Yours truly, For Anthem Biosciences Limited (Formerly known as Anthem Biosciences Private Limited) Divya Prasad Company Secretary & Compliance Officer Membership No: A41438 vishwavani.news